Cole Eye Institute Outcomes
About Glaucoma Surgery
Glaucoma is the second most common cause of irreversible blindness in the United States, after age-related macular degeneration. While visual loss from glaucoma cannot be reversed, adequate control of intraocular pressure (IOP) can halt or slow the progressive loss of vision.
Medications such as eye drops can help patients avoid the need for laser treatment or surgery, but these entail long-term cost and some potential for local and systemic side effects. Laser treatment for glaucoma is generally quick, safe, and convenient, but in many patients it has only a relatively small effect in reducing IOP and the effect may wear off over time. For some patients, surgery to control IOP, and prevent glaucoma progression, is the best option.
Glaucoma implants, trabeculectomies, iStent® trabecular micro-bypass, and cyclophotocoagulation are the mainstays of glaucoma surgery at Cole Eye Institute. In addition, newer procedures being performed are goniotomy and gonioscopy-assisted transluminal trabeculectomy (GATT).
Volume of All Glaucoma Surgeries
2015 - 2018
GATT = gonioscopy-assisted transluminal trabeculectomy
Volume of Trabeculectomy and Glaucoma Implant Surgeries
2015 – 2018
Volume of iStent, Cyclophotocoagulation, Goniotomy, and GATT
2015 – 2018
CPC = cyclophotocoagulation, GATT = gonioscopy-assisted transluminal trabeculectomy